Hemodialysis Patients Clinical Trial
Official title:
The Effect of Mindfulness Compassionate Life Practice on Stress, Self-Efficacy and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study
There are studies evaluating the effects of mindfulness-based practices on individuals receiving HD treatment. No studies have been found on how Mindfulness Compassionate Life application reduces stress, increases self-efficacy and quality of life in individuals receiving HD treatment. Considering the stress situations experienced by individuals receiving HD treatment, it is thought that the evidence-based effect of Mindfulness Compassionate Living application on individuals' stress, self-efficacy and quality of life is important. The population of the research will consist of 90 Hemodialysis patients who were treated in Bingöl State Hospital Dialysis Unit during the specified date range. Sample size of the research; Calculated using the GPower computer program. With the power analysis, it was calculated that at the α = 0.05 level, the effect size would be strong 150, 153 (d = 0.8) and the power of the study would be 90%, and that at least 68 patients should be included in the sample. Patients who meet the research criteria and agree to participate in the research will be randomly assigned to one experimental and one control group.
Introductory information form prepared by the researcher in line with the literature and containing the socio-demographic data of hemodialysis patients, Perceived Stress Scale (PSS) to evaluate stress, Self-Efficacy-Efficacy Scale (SEES) to evaluate self-efficacy, SF-12 Quality of Life Scale to evaluate quality of life. , Self-Compassion Scale Short Form (PSS-K) will be used to evaluate self-compassion, and Conscious Mindfulness Scale (BIPS) will be used to evaluate conscious mindfulness. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06382701 -
Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation
|
N/A | |
Completed |
NCT04674930 -
Effects of Exercise Program on Physical Functioning of Hemodialysis Patients.
|
N/A | |
Recruiting |
NCT02245633 -
Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients
|
N/A | |
Recruiting |
NCT01970280 -
Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.
|
Phase 4 | |
Completed |
NCT06165211 -
Nature-Based Sound Application For Hemodialysis Patients
|
N/A | |
Completed |
NCT06106763 -
Mandala Colouring On Anxiety, Depression, Pain And Quality of Life
|
N/A | |
Completed |
NCT05693584 -
The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients
|
N/A | |
Completed |
NCT01932853 -
Association Between Dose Dialysis by Kt and Mortality
|
N/A | |
Completed |
NCT01273974 -
The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients
|
Phase 2/Phase 3 | |
Completed |
NCT04139759 -
THE EFFECT OF HAND AND FOOT MASSAGE ON FATIGUE IN HEMODIALYSIS PATIENTS
|
N/A | |
Not yet recruiting |
NCT05574595 -
Effect on Pain and Comfort Associated With Fistula Puncture
|
N/A | |
Completed |
NCT04175652 -
Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality
|
N/A | |
Not yet recruiting |
NCT06314243 -
The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients
|
Phase 3 | |
Completed |
NCT01596842 -
Effect of Omega-3 Fatty Acid on Vitamin D Activation
|
Phase 4 | |
Enrolling by invitation |
NCT01896882 -
Dietary Sodium Restriction in Hemodialysis Patients
|
N/A | |
Completed |
NCT00638300 -
Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)
|
N/A | |
Terminated |
NCT00259714 -
Dialysate Sodium Individualization in Hemodialysis
|
Phase 1 | |
Completed |
NCT01846754 -
Prevalence of Fatigue in Hemodialysis Patients
|
N/A | |
Completed |
NCT00491868 -
Clinical Study of R744 to Hemodialysis Patients
|
Phase 3 | |
Completed |
NCT04195919 -
The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients
|
Phase 1 |